Riskpilot← Back to searchSign inGet full accessECLIPSE BIOFARM AKTIEBOLAG
ABActiveOrg 5562664036Hålarpsvägen 15Manufacture of prepared feeds for farm animals · NACE 1091Est. 19855 employees
Revenue 2024
SEK 14,5M
-10% vs 2023
EBITDA margin
2.4%
-42% vs 2023
Equity ratio
29.9%
Financial strength
Net profit 2024
SEK 1K
-99% vs 2023
| Revenue | SEK 14,5M | -10% |
| EBITDA | SEK 347K | -42% |
| Net profit | SEK 1K | -99% |
| Total assets | SEK 10,1M | +3% |
| Equity | SEK 3M | +0% |
| Employees | 5 | — |
Legal name
ECLIPSE BIOFARM AKTIEBOLAG
Org number
5562664036
Legal form
Aktiebolag
NACE code
1091 · Manufacture of prepared feeds for farm animals
Founded
18 november 1985
Share capital
SEK 200 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med suppleanten Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva tillverkning, köp och försäljning av framförallt hästsportartiklar ävensom idka därmed förenlig verksamhet.
Address
Hålarpsvägen 15
Email
ekonomi@willab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 155 | 15 460 | 16 884 | 16 061 | 14 465 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 097 | 1 127 | 1 301 | 602 | 347 |
| Depreciation & amort. | −336 | −347 | −250 | −273 | −343 |
| EBIT | 1 761 | 780 | 1 051 | 329 | 4 |
| Net financials | −3 | −1 | −51 | −190 | −230 |
| Profit before tax | 43 | 540 | 703 | 76 | 7 |
| Tax | −27 | −95 | −178 | −6 | −6 |
| Net profit | 16 | 445 | 525 | 70 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 768 | 7 116 | 11 650 | 9 806 | 10 107 |
| Equity | 1 978 | 2 423 | 2 948 | 3 019 | 3 019 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 436 | 4 094 | 7 800 | 5 818 | 6 348 |
| Total debt | 2 436 | 4 094 | 7 800 | 5 818 | 6 348 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
29.9%
This company
38.2%
Market median
-22% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20202024
Debt / equity
2.35×
This company
0.62×
Market median
-279% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AL Chief Executive Officer | Chief Executive Officer | 2024 |
EG Chief Auditor | Chief Auditor | 2020 |
| Former (2) | ||
LJ Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
PJ Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ekhaga Utveckling AB
ECLIPSE BIOFARM AKTIEBOLAG Board members of ECLIPSE BIOFARM AKTIEBOLAG also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annie Louise Strand | Chief Executive Officer | 0 companies |
| Lars Jacob Atthage | Chief Executive Officer | 0 companies |
| Per Johan Burtus | Chief Executive Officer | 0 companies |
| Eric Gunnar Salander | Chief Auditor | 0 companies |
| Per Erik Gullstrand | Chairman | 0 companies |
| Karl Fredrik Ludvig Paulsson | Board of Directors | 0 companies |
| Susanne Maria Atmer Meinl | Deputy Board Member | 0 companies |